<DOC>
	<DOC>NCT00586378</DOC>
	<brief_summary>The purpose of this post-approval study is to confirm the safety and effectiveness of Ovatio DR and VR ICDs</brief_summary>
	<brief_title>Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study</brief_title>
	<detailed_description />
	<mesh_term>Death</mesh_term>
	<mesh_term>Death, Sudden, Cardiac</mesh_term>
	<criteria>Candidates will come from the investigator's general ICD population who meet any of the accepted indications for an ICD implant according to the "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death" (Zipes et al., JACC Vol. 48, No. 5, Sept. 2006:10641108). Ventricular tachyarrhythmia that may have transient or reversible causes such as: acute myocardial infarction, digitalis intoxication, drowning, electrocution, electrolyte imbalance, hypoxia, sepsis, or unstable ischemic episodes Incessant tachyarrhythmia Implanted pacemaker Primary disorder of bradyarrhythmia or atrial tachyarrhythmia Of minor age Pregnant Participating in another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>